| ||
| Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 ... PR Newswire (press release) Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer. The company's most advanced drug candidates in clinical development are TELINTRA, ... See all stories on this topic » | ||
| Biomoda Completes Patient Enrollment and Sample Collection for Pilot Study Trading Markets (press release) "We believe initial results will show that our assay can both identify and quantify lung cell characteristics that differ between groups of individuals at high risk for developing cancer and those who already have the disease. ... See all stories on this topic » | ||
| Times-Union Reporter Honored WJXT Jacksonville In March 2009, Kerr was diagnosed with small-cell lung cancer. The journalism veteran has chronicled her battle against the disease in a blog on jacksonville.com. Kerr is said to be one of the most established reporters in Jacksonville. See all stories on this topic » | ||
| Nanoscaled carborane ruthenium(II)-arene complex inducing lung cancer cells ... 7thSpace Interactive (press release) Results: In this study, the ruthenium(II)-arene complex could significantly induce apoptosis in human lung cancer HCC827 cell line. At the concentration range of 5muM-100muM, ruthenium(II)-arene complex had obvious cell growth inhibition effect on ... See all stories on this topic » | ||
| Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung ... 7thSpace Interactive (press release) Conclusions: This is the first reported study focusing on the association between MTHFR C677T polymorphisms and the risk of lung cancer in a Korean population. The T allele was found to provide a weak protective association with lung squamous cell ... See all stories on this topic » | ||
| Jefferson's Department of Radiation Oncology Recruits Nicole Simone, M.D., and ... Newswise (press release) Dr. Lu's focus is on radiation-induced cell death in lung patients, among other basic science areas. His clinical interests include the integration of novel targeted agents in the treatment of lung cancer, radiosurgery for lung cancer, and reduction of ... See all stories on this topic » | ||
| 'Key' to cancer spread tested in mice NHS Choices However, the researchers found that mice injected with tumour cell lines that had LOXL2 knocked down or inhibited with D-penicillamine had fewer secondary lung or liver tumours than mice injected with cell lines that made high levels of LOX2L. ... See all stories on this topic » |
| ||
| Outcomes of Patients with Advanced Non-Small Cell Lung Cancer ... Phase I • Non-small cell lung cancer • Survival. Correspondence: Correspondence: Filip Janku, M.D., Ph.D., Department of Investigational Cancer Therapeutics ... theoncologist.alphamedpress.org/.../theoncologist.2010-0308v... | ||
| incurable lung cancer - Macmillan's Online Community My father has just been diagnosed with lung cancer (Non small cell) in both lungs. We sort of knew it was going to be cancer , but was shocked to find out ... community.macmillan.org.uk/groups/lung.../p/.../405577.aspx | ||
| lung cancer - Site Notification – CarePages Discussion Forums My 79 year old Mother has stage 4 non-small cell lung cancer. It is inoperable. She has had four rounds of chemotherapy every 21 days. ... %3cbr%3ewww.carepages.com/forums/site.../topics/77949 |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment